Hunter Syndrome.
Kumar P, Das PC, Das A.
JAMA Dermatol. 2022 Dec 1;158(12):1438. doi: 10.1001/jamadermatol.2022.4049.
Bow hunter syndrome.
Kühn AL, McGillicuddy GT, Singh J.
CMAJ. 2022 Nov 7;194(43):E1486. doi: 10.1503/cmaj.220607.
Molecular basis of mucopolysaccharidosis type II (Hunter syndrome): first review and classification of published IDS gene variants.
Zanetti A, D'Avanzo F, Tomanin R.
Hum Genomics. 2024 Dec 2;18(1):134. doi: 10.1186/s40246-024-00701-w.
Hunter Syndrome: Is It Time to Make It Part of Newborn Screening?
Joseph R, DiCesare EB, Miller A.
Adv Neonatal Care. 2018 Dec;18(6):480-487. doi: 10.1097/ANC.0000000000000569.
Idursulfase in Hunter syndrome treatment.
Zareba G.
Drugs Today (Barc). 2007 Nov;43(11):759-67. doi: 10.1358/dot.2007.43.11.1157619.
Multidisciplinary management of Hunter syndrome.
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E.
Pediatrics. 2009 Dec;124(6):e1228-39. doi: 10.1542/peds.2008-0999. Epub 2009 Nov 9.
Bow Hunter's syndrome combined with ipsilateral vertebral artery dissection/pseudoaneurysm: case study and literature review.
Xue S, Shi H, Du X, Ma X.
Br J Neurosurg. 2023 Aug;37(4):911-915. doi: 10.1080/02688697.2020.1718604. Epub 2020 Feb 3.
Mucopolysaccharidosis type II, Hunter's syndrome.
Tylki-Szymańska A.
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:107-13.
Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment.
Mohamed S, He QQ, Singh AA, Ferro V.
Adv Carbohydr Chem Biochem. 2020;77:71-117. doi: 10.1016/bs.accb.2019.09.001. Epub 2019 Oct 26.
Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment.
D'Avanzo F, Rigon L, Zanetti A, Tomanin R.
Int J Mol Sci. 2020 Feb 13;21(4):1258. doi: 10.3390/ijms21041258.
